EdgarLookup
SC 13D/A

AMENDMENT NO. 5 TO THE SCHEDULE 13D

Company
Oruka Therapeutics, Inc.
Filed
June 21, 2022
Accession Number
0000921895-22-002046
View Document ↗ View on SEC.gov ↗